C000020224 Fees and Costs — Allspring Target 2010 Fund, Class A
Data updated: 2022-07-29
The net expense ratio is 0.60% (0.89% before fee waivers). This share class carries a maximum front-end sales load of 5.75%. Portfolio turnover was 106%.
C000020224 Fees and Expenses
Annual operating expenses and sales charges of C000020224. Prospectus, as of June 30, 2022.
| Annual operating expenses | |
|---|---|
| Management fee | 0.10% |
| 12b-1 fee | 0.00% |
| Other expenses | 0.70% |
| Gross expense ratio | 0.89% |
| Fee waiver | −0.29% |
| Net expense ratio | 0.60% |
| Sales charges | |
|---|---|
| Max front load | 5.75% |
| Max deferred load | 0.00% |
| Redemption fee | — |
| Expense limitation in place (N-CEN) | Yes |
| Fees waived or reduced during the year | Yes |
| Waived fees subject to recoupment | No |
C000020224 Costs Over Time
On $10,000 invested in C000020224, assuming 5% a year before costs, total costs come to $1,090 over 5 years, cutting the return by 1.86% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).
| $10,000 invested | Sell after 1 year | Sell after 3 years | Sell after 5 years |
|---|---|---|---|
| Value before costs | $10,500 | $11,576 | $12,763 |
| Sales charges | $575 | $575 | $575 |
| Fund expenses (net expense ratio 0.60%) | $59 | $186 | $324 |
| Lost growth on money paid in costs | $29 | $100 | $191 |
| Total costs | $663 | $861 | $1,090 |
| Value after costs | $9,837 | $10,715 | $11,672 |
| Impact on return, per year | 6.63% | 2.67% | 1.86% |
C000020224 Trading Costs
Brokerage costs reported on SEC Form N-CEN for the fiscal year ending February 28, 2022.
- Explicit cost rate (commissions ÷ average net assets): —
- Total broker commissions: —
- Bought from dealers (principal trades, not a cost): —
- Portfolio turnover (prospectus): 106%
- Securities lending: none during the year
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.